Clinical Trial Update: Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating erlotinib with concurrent brain radiotherapy and secondary brain radiotherapy after recurrence in patients with non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Wu Jieping Medical Foundation | Conditions: Non-small-cell Lung Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN